Company profile
Acurx Pharmaceuticals, Inc. Insider Trading
ACXPEvery SEC Form 4 insider trading filing for Acurx Pharmaceuticals, Inc. (ACXP) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001736243
- Filings
- 33
- Insiders
- 8
- Last filing
- 2026-04-20
Activity summary
No insider transactions in the last 30 days. The most recent was on April 20, 2026, when Shawah Robert G. bought 25,900 shares. 33 filings from 8 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q4 21 to Q2 26. Acurx Pharmaceuticals, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $210K.
No insider activity recorded for ACXP in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Shawah Robert G. | ACXP | Award | 25,900 | — | — |
| Apr 20, 2026 | Sailer Carl | ACXP | Award | 2,150 | — | — |
| Apr 20, 2026 | Dean Jack H | ACXP | Award | 2,150 | — | — |
| Apr 20, 2026 | Donohue James J. | ACXP | Award | 2,150 | — | — |
| Apr 20, 2026 | Harrison Thomas L | ACXP | Award | 2,150 | — | — |
40 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ACXP" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Acurx Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →